D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
The striatum, which is the major component of the basal ganglia in the brain, is regulated in part by dopaminergic input from the substantia nigra. Severe movement disorders result from the loss of striatal dopamine in patients with Parkinson's disease. Rats with lesions of the nigrostriatal dopamine pathway caused by 6-hydroxydopamine (6-OHDA) serve as a model for Parkinson's disease and show alterations in gene expression in the two major output systems of the striatum to the globus pallidus and substantia nigra. Striatopallidal neurons show a 6-OHDA-induced elevation in their specific expression of messenger RNAs (mRNAs) encoding the D 2 dopamine receptor and enkephalin, which is reversed by subsequent continuous treatment with the D 2 agonist quinpirole. Conversely, striatonigral neurons show a 6-OHDA-induced reduction in their specific expression of mRNAs encoding the D 1 dopamine receptor and substance P, which is reversed by subsequent daily injections of the D 1 agonist SKF-38393. This treatment also increases dynorphin mRNA in striatonigral neurons. Thus, the differential effects of dopamine on striatonigral and striatopallidal neurons are mediated by their specific expression of D 1 and D 2 dopamine receptor subtypes, respectively.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The NAc is composed of a vast array of transcriptionally distinct neuronal subtypes, where medium spiny neurons (MSNs) make up the majority (>95%) of the cells (16).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [16]
In the citing paper
“These neurons are defined by their transcriptional profiles, including dopamine receptor 1 (D1) vs. dopamine receptor 2 (D2) expression, substance P and enkephalin, and other enriched genes (16–18).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [16]
Citations
Cites
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,725
DOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION
HORNYKIEWICZ, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,442
Fluoro-gold: a new fluorescent retrograde axonal tracer with numerous unique properties
Schmued, L. C., & Fallon, J. H. (1986) · Brain Research · doi:10.1016/0006-8993(86)91199-6 · Cited by 886
Freund, T. F., Powell, J. F., & Smith, A. D. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90294-x · Cited by 865
Hikosaka, O., & Wurtz, R. H. (1983) · Journal of Neurophysiology · doi:10.1152/jn.1983.49.5.1285 · Cited by 808
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young, W. S., Bonner, T. I., & Brann, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9827 · Cited by 743
Gerfen, C. R., & Scott Young, W. (1988) · Brain Research · doi:10.1016/0006-8993(88)91217-6 · Cited by 658
Self-citationMultiple D2 dopamine receptors produced by alternative RNA splicing
Monsma, F. J., McVittie, L. D., Gerfen, C. R., Mahan, L. C., & Sibley, D. R. (1989) · Nature · doi:10.1038/342926a0 · Cited by 641
Self-citationProjection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin
Kawaguchi, Y., Wilson, C., & Emson, P. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-10-03421.1990 · Cited by 565
Research works printed but not linked: 1
- HONG, J.S., ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY 24: 223 (1980).
Cited by
Items 801–900 of 1,013
Wang, J. Q., & McGinty, J. F. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00597-8 · Cited by 74
Lindskog, M., Svenningsson, P., Fredholm, B. B., Greengard, P., & Fisone, G. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00411-4 · Cited by 74
Functional striatal hypodopaminergic activity in mice lacking adenosine A2A receptors
Dassesse, D., Massie, A., Ferrari, R., Ledent, C., Parmentier, M., Arckens, L., Zoli, M., & Schiffmann, S. N. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00389.x · Cited by 72
Pharmacological animal models of Tourette syndrome
Bronfeld, M., Israelashvili, M., & Bar‐Gad, I. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.09.010 · Cited by 73
Burbaud, P., Bonnet, B., Guehl, D., Lagueny, A., & Bioulac, B. H. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01158-x · Cited by 73
Melloni, R. H., & Ricci, L. A. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.11.002 · Cited by 73
Monville, C., Torres, E. M., & Dunnett, S. B. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.10.011 · Cited by 73
Anatomy and physiology of the basal ganglia: relevance to Parkinson's disease and related disorders
Wichmann, T., & DeLong, M. R. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83001-6 · Cited by 73
Berthele, A., Platzer, S., Jochim, B., Boecker, H., Büttner, A., Conrad, B., Riemenschneider, M. J., & Toelle, T. R. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.05.030 · Cited by 73
Modulation of histamine H3 receptors in the brain of 6‐hydroxydopamine‐lesioned rats
Anichtchik, O. V., Huotari, M., Peitsaro, N., Haycock, J. W., Männistö, P. T., & Panula, P. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00267.x · Cited by 73
Indirect-pathway neurons lose their spines in Parkinson disease
Gerfen, C. R. (2006) · Nature Neuroscience · doi:10.1038/nn0206-157 · Cited by 73
Self-citationJoyce, J. N. (1991) · Experimental Neurology · doi:10.1016/0014-4886(91)90017-7 · Cited by 73
Egervari, G., Ciccocioppo, R., Jentsch, J. D., & Hurd, Y. L. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.019 · Cited by 72
Conserved role of dopamine in the modulation of behavior
Vidal-Gadea, A. G., & Pierce-Shimomura, J. T. (2012) · Communicative & Integrative Biology · doi:10.4161/cib.20978 · Cited by 72
Delfino, M., Stefano, A. V., Ferrario, J. E., Taravini, I. R. E., Murer, M. G., & Gershanik, O. S. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.10.009 · Cited by 72
Dysfunctional and compensatory synaptic plasticity in P arkinson's disease
Schroll, H., Vitay, J., & Hamker, F. H. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12434 · Cited by 72
Salinas, A. G., Davis, M. I., Lovinger, D. M., & Mateo, Y. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.049 · Cited by 72
Trichloroethylene and Parkinson’s Disease: Risk Assessment
Liu, M., Shin, E., Dang, D., Jin, C., Lee, P. H., Jeong, J. H., Park, S., Kim, Y., Xing, B., Xin, T., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0830-x · Cited by 72
Numan, S., Lundgren, K. H., Wright, D. E., Herman, J. P., & Seroogy, K. B. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00004-c · Cited by 72
Ibáñez-Sandoval, O., Hernández, A., Florán, B., Galarraga, E., Tapia, D., Valdiosera, R., Erlij, D., Aceves, J., & Bargas, J. (2005) · Journal of Neurophysiology · doi:10.1152/jn.01074.2005 · Cited by 72
Drago, J., Padungchaichot, P., Wong, J. Y. F., Lawrence, A. J., McManus, J. F., Sumarsono, S. H., Natoli, A. L., Lakso, M., Wreford, N. G., Westphal, H., et al. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09845.1998 · Cited by 72
Chen, J., Moratalla, R., Yu, L., Martín, A. B., Xu, K., Bastia, E., Hackett, E., Alberti, I., & Schwarzschild, M. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300152 · Cited by 72
Zeng, B. ‐., Jolkkonen, J., Jenner, P. G., & MARSDEN, C. D. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00574-o · Cited by 72
Studying Brain Circuit Function with Dynamic Causal Modeling for Optogenetic fMRI
Bernal-Casas, D., Lee, H. J., Weitz, A. J., & Lee, J. H. (2017) · Neuron · doi:10.1016/j.neuron.2016.12.035 · Cited by 71
Parievsky, A., Moore, C., Kamdjou, T., Cepeda, C., Meshul, C. K., & Levine, M. S. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.020 · Cited by 71
Nelson, A., Abdelmesih, B., & Costa, R. M. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00939-w · Cited by 71
Enhancer AAV toolbox for accessing and perturbing striatal cell types and circuits
Hunker, A. C., Wirthlin, M. E., Gill, G., Johansen, N., Hooper, M. J., Omstead, V., Vargas, S., Lerma, M. N., Taskin, N., Weed, N., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.04.035 · Cited by 71
Cognition and the inhibitory control of saccades in schizophrenia and Parkinson's disease
Crawford, T. J., Bennett, D., Lekwuwa, G., Shaunak, S., & Deakin, J. F. W. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)40068-4 · Cited by 71
Manciocco, A., Chiarotti, F., Vitale, A., Calamandrei, G., Laviola, G., & Alleva, E. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.08.002 · Cited by 71
Untangling dopamine-adenosine receptor assembly in experimental parkinsonism
Fernández‐Dueñas, V., Taura, J. J., Cottet, M., Gómez‐Soler, M., López‐Cano, M., Ledent, C. A., Watanabe, M., Trinquet, E., Pin, J., Luján, R., et al. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.018143 · Cited by 71
Antiparkinsonian Action of a δ Opioid Agonist in Rodent and Primate Models of Parkinson's Disease
Hille, C. J., Fox, S. H., Maneuf, Y. P., Crossman, A. R., & Brotchie, J. M. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7763 · Cited by 71
West, A. R., & Tseng, K. Y. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00055 · Cited by 71
Direct and GABA‐mediated indirect effects of nicotinic ACh receptor agonists on striatal neurones
Luo, R., Janssen, M. J., Partridge, J. G., & Vicini, S. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.241786 · Cited by 71
Zhang, Q., Zhang, Y., Wang, C., Xu, Z., Liang, Q., An, L., Li, J., Liu, Z., You, Y., He, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.090 · Cited by 71
The Neuroanatomical Organization of the Basal Ganglia
Gerfen, C. R., & Bolam, J. P. (2016) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-802206-1.00001-5 · Cited by 71
Self-citationChapter VI Dopamine systems in the primate brain
Lewis, D. A., & Sesack, S. R. (1997) · Handbook of chemical neuroanatomy · doi:10.1016/s0924-8196(97)80008-5 · Cited by 71
Carta, A. R., Tronci, E., Pinna, A., & Morelli, M. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03944.x · Cited by 71
Bianchi, L., Galeffi, F., Bolam, J. P., & Corte, L. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02795.x · Cited by 71
Reader, T. A., & Dewar, K. M. (1999) · Neurochemistry International · doi:10.1016/s0197-0186(98)00048-5 · Cited by 71
Neuropathophysiology of Movement Disorders in Cerebral Palsy
Filloux, F. M. (1996) · Journal of Child Neurology · doi:10.1177/0883073896011001s02 · Cited by 71
Pollack, A. E., & Fink, J. S. (1996) · Brain Research · doi:10.1016/s0006-8993(96)01036-0 · Cited by 71
Helie, S., Chakravarthy, S., & Moustafa, A. A. (2013) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2013.00174 · Cited by 70
Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy
Landvogt, C., Buchholz, H., Bernedo, V., Schreckenberger, M., & Werhahn, K. J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02569.x · Cited by 70
Dopaminergic system in birdsong learning and maintenance
Kubíková, Ľ., & Košťál, Ľ. (2009) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2009.10.004 · Cited by 70
Novak, M., Halbout, B., O'Connor, E. C., Rodriguez Parkitna, J., Su, T., Chai, M., Crombag, H. S., Bilbao, A., Spanagel, R., Stephens, D. N., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2550-10.2010 · Cited by 63
Calhoun, S. E., Meunier, C. J., Lee, C. A., McCarty, G. S., & Sombers, L. A. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00351 · Cited by 70
Nucleus accumbens fast-spiking interneurons in motivational and addictive behaviors
Schall, T. A., Wright, W. J., & Dong, Y. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0683-y · Cited by 70
Marti, M., Mela, F., Bianchi, C., Beani, L., & Morari, M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01169.x · Cited by 60
[11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease
Kumar, A., Mann, S. K., Sossi, V., Ruth, T. J., Stoessl, A. J., Schulzer, M., & Lee, C. S. (2003) · Brain · doi:10.1093/brain/awg270 · Cited by 70
Richtand, N. M., Kelsoe, J. R., Segal, D. S., & Kuczenski, R. T. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00112-6 · Cited by 70
Starr, M. S. (1995) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02251229 · Cited by 70
Pollack, A. E., Harrison, M. B., Wooten, G. F., & Fink, J. S. (1993) · Brain Research · doi:10.1016/0006-8993(93)91204-6 · Cited by 70
Maguire, E. P., Macpherson, T., Swinny, J. D., Dixon, C. I., Herd, M. B., Belelli, D., Stephens, D. N., King, S. L., & Lambert, J. J. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3232-13.2014 · Cited by 69
Emx1 -Lineage Progenitors Differentially Contribute to Neural Diversity in the Striatum and Amygdala
Cocas, L. A., Miyoshi, G., Carney, R. S. E., Sousa, V. H., Hirata, T., Jones, K. R., Fishell, G., Huntsman, M. M., & Corbin, J. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2525-09.2009 · Cited by 69
The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson’s Disease
Mori, A., Chen, J., Uchida, S., Durlach, C., King, S. M., & Jenner, P. G. (2022) · Molecules · doi:10.3390/molecules27072366 · Cited by 70
A spiking Basal Ganglia model of synchrony, exploration and decision making
Mandali, A., Rengaswamy, M., Chakravarthy, V. S., & Moustafa, A. A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00191 · Cited by 69
Presynaptic Receptors for Dopamine, Histamine, and Serotonin
Feuerstein, T. J. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-74805-2_10 · Cited by 69
Physiology of the normal and dopamine-depleted basal ganglia: Insights into levodopa pharmacotherapy
Grace, A. A. (2008) · Movement Disorders · doi:10.1002/mds.22020 · Cited by 69
Gelman, B. B., Spencer, J. A., Holzer, C. E., & Soukup, V. M. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9030-6 · Cited by 69
Wang, L., Rangarajan, K. V., Gerfen, C. R., & Krauzlis, R. J. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.049 · Cited by 69
Self-citationGDNF reverses priming for dyskinesia in MPTP‐treated, l ‐DOPA‐primed common marmosets
Iravani, M. M., Costa, S., Jackson, M. J., Tel, B. C., Cannizzaro, C., Pearce, R. K. B., & Jenner, P. G. (2001) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2001.01408.x · Cited by 69
Kindlundh, A. M. S., Lindblom, J., Bergström, L., & Nyberg, F. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00120-9 · Cited by 69
Wong, A. C., Shetreat, M. E., Clarke, J. O., & Rayport, S. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00284-x · Cited by 69
Reiner, A. J., Medina, L. M., & Haber, S. N. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00254-1 · Cited by 69
Kelly, S. M., Raudales, R., He, M., Lee, J. H., Kim, Y., Gibb, L. G., Wu, P., Matho, K., Osten, P., Graybiel, A. M., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.06.021 · Cited by 68
Svenningsson, P., Fredholm, B. B., Bloch, B., & Moine, C. L. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00155-x · Cited by 68
Toward sophisticated basal ganglia neuromodulation: Review on basal ganglia deep brain stimulation
Cunha, C. D., Boschen, S. L., Gómez‐A, A., Ross, E. K., Gibson, W. S. J., Min, H.-K. P., Lee, K. H., & Blaha, C. D. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.02.003 · Cited by 68
Shin, M., Jeong, H.-Y., An, D.-I., Lee, H.-Y., & Sung, Y.-H. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.015 · Cited by 68
Cellular and molecular aspects of striatal development
Jain, M., Armstrong, R. J. E., Barker, R. A., & Rosser, A. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00555-x · Cited by 68
Bézard, E., Ravenscroft, P., Gross, C. E., Crossman, A. R., & Brotchie, J. M. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0375 · Cited by 68
Laprade, N., & Soghomonian, J. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00139-j · Cited by 68
Dopamine receptors in the basal ganglia: Relevance to parkinson's disease
Strange, P. G. (1993) · Movement Disorders · doi:10.1002/mds.870080303 · Cited by 68
Morari, M., O'Connor, W. T., Ungerstedt, U., & Fuxé, K. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90611-4 · Cited by 68
Cortical-subcortical interactions in goal-directed behavior
Cruz, K. G., Leow, Y. N., Le, N. M., Adam, E., Huda, R., & Sur, M. (2023) · Physiological Reviews · doi:10.1152/physrev.00048.2021 · Cited by 67
Dysfunctional striatal dopamine signaling in Huntington's disease
Koch, E. T., & Raymond, L. A. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24495 · Cited by 67
Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia
Farré, D., Muñoz, A., Moreno, E., Reyes‐Resina, I., Canet-Pons, J., Dopeso‐Reyes, I. G., Rico, A. J., Lluís, C., Mallol, J., Navarro, G., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8936-x · Cited by 67
Kitaoka, S., Furuyashiki, T., Nishi, A., Shuto, T., Koyasu, S., Matsuoka, T., Miyasaka, M., Greengard, P., & Narumiya, S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3257-07.2007 · Cited by 67
Deffains, M., & Bergman, H. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.12.015 · Cited by 67
Learning processing in the basal ganglia: A mosaic of broken mirrors
Cunha, C. D., Lovato, E. C. W., Dombrowski, P. A., Bortolanza, M., dos Santos, L. M., Boschen, S. L., & Miyoshi, E. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.001 · Cited by 67
Naidu, P. S., & Kulkarni, S. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200105000-00006 · Cited by 67
Langlois, M.-C., Beaudry, G., Zekki, H., Rouillard, C., & Lévesque, D. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00248-2 · Cited by 67
Larson, E. R., & Ariano, M. A. (1995) · Synapse · doi:10.1002/syn.890200406 · Cited by 67
Campbell, K., & Björklund, A. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00328.x · Cited by 67
Striosomes control dopamine via dual pathways paralleling canonical basal ganglia circuits
Lazaridis, I., Crittenden, J. R., Ahn, G., Hirokane, K., Wickersham, I. R., Yoshida, T., Mahar, A., Skara, V., Loftus, J., Parvataneni, K., et al. (2024) · Current Biology · doi:10.1016/j.cub.2024.09.070 · Cited by 67
Probing Deep Brain Circuitry: New Advances in in Vivo Calcium Measurement Strategies
Girven, K. S., & Sparta, D. R. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00307 · Cited by 66
Georges, F. E., Stinus, L., & Moine, C. L. (2000) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01334.x · Cited by 66
Wang, J. Q., & McGinty, J. F. (1995) · Brain Research · doi:10.1016/0006-8993(94)01422-e · Cited by 66
Meshul, C. K., Cogen, J. P., Cheng, H. W., Moore, C., Krentz, L., & McNeill, T. H. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7467 · Cited by 66
Blanchet, P. J., Grondin, R., & Bédard, P. J. (1996) · Movement Disorders · doi:10.1002/mds.870110117 · Cited by 66
O’Donovan, M. C., Buckland, P. R., Spurlock, G., & McGuffin, P. (1992) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(92)90051-v · Cited by 66
Modeling Huntington's disease with induced pluripotent stem cells
Kaye, J. A., & Finkbeiner, S. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.02.005 · Cited by 65
Cui, W., Aida, T., Ito, H., Kobayashi, K., Wada, Y., Kato, S., Nakano, T., Zhu, M., Isa, K., Kobayashi, K., et al. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0444-20.2020 · Cited by 65
Bonnavion, P., Varin, C., Fakhfouri, G., Olondo, P. M., Groote, A. D., Cornil, A., Lopez, R. L., Fernández, E. P., Isingrini, E., Rainer, Q., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01694-4 · Cited by 65
Hemispheric differences in the mesostriatal dopaminergic system
Molochnikov, I., & Cohen, D. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00110 · Cited by 65
Enoksson, T., Bertran‐Gonzalez, J., & Christie, M. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.02.020 · Cited by 65
Heckman, P. R. A., van Duinen, M. A., Bollen, E., Nishi, A., Wennogle, L. P., Blokland, A., & Prickaerts, J. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw030 · Cited by 65
Reiner, A. J., Perera, M. A., Paullus, R., & Medina, L. M. (1998) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(98)00056-8 · Cited by 65
Simpson, C. S., & Morris, B. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00122-y · Cited by 65
D2 dopamine receptor localization on striatonigral neurons
Ariano, M. A., Stromski, C. J., Smyk-Randall, E. M., & Sibley, D. R. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90753-t · Cited by 65
Self-citationD2 dopamine receptor distribution in the rodent CNS using anti-peptide antisera
Ariano, M. A., Fisher, R. S., Smyk-Randall, E. M., Sibley, D. R., & Levine, M. S. (1993) · Brain Research · doi:10.1016/0006-8993(93)90857-j · Cited by 65
Self-citation
Metadata
- Authors
- Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R.
- Affiliations
- National Institutes of Health (US)
- Venue
- Science
- Published
- 1990-12-07
- Volume
- 250
- Issue
- 4986
- Pages
- 1429-1432
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1991603311
- Cited by
- 2,967
- References
- 38
- Citations by year
- 2026: 54 · 2025: 60 · 2024: 73 · 2023: 64 · 2022: 89 · 2021: 84 · 2020: 79 · 2019: 85 · 2018: 90 · 2017: 79 · 2016: 102 · 2015: 106 · 2014: 95 · 2013: 79 · 2012: 97
- FWCI
- 27.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- dopamine D1 receptor, dopamine D2 receptor, striatonigral neurons, striatopallidal neurons, gene expression, 6-hydroxydopamine lesion, Parkinson's disease model, substantia nigra, globus pallidus, enkephalin, substance P, dynorphin, quinpirole, SKF 38393, basal ganglia, dopamine agonists
- MeSH terms
- Animals, Cerebral Cortex, Corpus Striatum, Ergolines, Gene Expression Regulation, Globus Pallidus, Hydroxydopamines, Models, Neurological, Neurons, Receptors, Dopamine, RNA, Messenger, Substantia Nigra, Thalamus, Oligonucleotide Probes, 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine, Oxidopamine, Receptors, Dopamine D1, Receptors, Dopamine D2, Quinpirole, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.